In 2021, President Biden directed the FDA to lower prices on generic prescriptions and to import medication from Canada. Which of the following best summarizes what factors went into the president’s cost-benefit analysis for this market?(1 point)

Question

Responses

The president considered the cost for medical care in the U.S., the cost for prescriptions in Canada, and the benefits for Americans purchasing medicine from overseas.
The president considered the cost for medical care in the U.S., the cost for prescriptions in Canada, and the benefits for Americans purchasing medicine from overseas.

The president considered the cost for prescriptions in the U.S., the cost for prescriptions in Canada, and the benefits for Americans traveling across the border to see a physician.
The president considered the cost for prescriptions in the U.S., the cost for prescriptions in Canada, and the benefits for Americans traveling across the border to see a physician.

The president considered the cost for prescriptions in Mexico, the cost for prescriptions in Canada, and the benefits for Americans purchasing from both countries.
The president considered the cost for prescriptions in Mexico, the cost for prescriptions in Canada, and the benefits for Americans purchasing from both countries.

The president considered the cost for prescriptions in the U.S., the cost for prescriptions in Canada, and the benefits for Americans purchasing from both countries.

Answer 1

The best summary of the factors that went into President Biden's cost-benefit analysis for the market would be:

The president considered the cost for prescriptions in the U.S., the cost for prescriptions in Canada, and the benefits for Americans purchasing from both countries.

This option accurately reflects the focus on prescription costs in both the U.S. and Canada, as well as the potential benefits of accessing medication from both markets.